Dalteparin versus aspirin in recent-onset branch retinal vein occlusion: A randomized clinical trial

Archives of Iranian Medicine

Volumn 11, Issue 4, 2008, Pages 418-422

  Farahvash, Mohammad Sadegh ^a   Moradimogadam, Marzieh ^a,b   Farahvash, Mohammad Mehdi ^a,b   Mohammadzadeh, Shiva ^a   Mirshahi, Ahmad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE   (Iran)

Author keywords

Aspirin; Branch retinal vein occlusion (BRVO); Dalteparin; Low molecular weight heparin (LMVH)

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; BRANCH RETINAL VEIN OCCLUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; ECCHYMOSIS; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE REACTION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; THROMBOCYTOPENIA; VISUAL ACUITY;

ASPIRIN; DALTEPARIN; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; TIME FACTORS;

EID: 48449101508     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Figueroa MS, Torres R, Alvarez MT. Comparative study of vitrectomy with and without vein decompression for branch retinal vein occlusion: a pilot study. Eur J Ophthalmol. 2004; 14: 40-47.
2. Sanborn GE. Venous occlusive disease of retina. In: Tasman W, Jaeger E, eds. Duane's Clinical Ophthalmology. Chapter 15. Philadelphia: Lippincott. Revision; 1996: 3.
3. Liesegang TJ, Deutsch TA, Grand MG. Retinal Vascular Disease, in Basic and Clinical Science Course. Section 12; Chapter 5. San Francisco: Foundation of the American Academy of Ophthalmology. 2001 - 2002: 127-131.
4. Cahill MT, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B12, and thermo labile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol. 2003; 36: 1136-1149.
5. Hayreh SS, Zimmerman MB, Podhajsky P. Hematologic abnormalities associated with various types of retinal vein occlusion. Arch Ophthalmol. 2002; 240: 180-196
6. Tekeli O, Gursel E, Buyurgan H. Protein C, protein S, and antithrombin III deficiencies in retinal vein occlusion. Acta Ophthalmol Scand. 1999; 77: 628-630.
7. Glacet-Bernard A, Kuhn D, Vine AK, Oubraham H, Coscas G, Soubrane G. Treatment of recent-onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol. 2000; 84: 609-613.
8. Achenbach LO, Weller-Mann G. Visual outcome after treatment with low-dose taps. Ophthalmologica. 1999; 213: 360-366.
9. Lahey JM, Fong DS, Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers. 1999; 30: 427-434.
10. Vannas S, Orma H. Experience of treating retinal venous occlusion with anticoagulant and antisclerosis therapy. Arch Ophthalmol. 1957; 58: 812-828.
11. The Branch Retinal Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984; 98: 271-282.
12. Handin RA, Anticoagulant, fibrinolytic, and antiplatelet therapy. In: Braunward E, Fausi AS, eds. Harrison's Principles of Internal Medicine. 15th ed. New York: McGraw-Hill; 2001: 758-760.
13. Harker LA. Antithrombotic therapy. In: Bennet JC, Plum F, eds. Cecil Textbook of Medicine. 21th ed. Philadelphia: Saunders; 2000: 119-122.
14. Romanowska B, Goszo A. Evaluation of fraxiparine efficiency in the treatment of retinal vein occlusion [in Polish]. Klin Oczna. 1999; 101: 451-454.
15. Kasymova S. Result of fraxiparine and ticlid therapy of acute retinal vessel occlusion. Vestnic Oftalmologies. 1998; 114: 21-24.
16. Stefano P, Cruzan S. Treatment of retinal vein occlusion with enoxaparin. SOE 2001.
17. Furie B, Furie BC. Molecular and cellular biology of blood coagulation. N Engl J Med. 1992; 326: 800-806.
18. Hirsh J. Heparin. N Engl J Med. 1991; 394: 1565-1574.
19. Frankelestein O, Clerks JG, BRVO Group Branch and Central Retinal Vein Occlusion. Focal Point. 1982. module 12: No.3.
20. Minamikawa M, Yamamoto K, Okuma H. Experimental retinal branch vein occlusion. 4. Pathological changes in the middle and late stage [in Japanese]. Nippon Ganka Gakkai Zasshi. 1993; 97: 920-927.